Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-4642

Polymenidou, M; Trusheim, H; Stallmach, L; Moos, R; Julius, C; Miele, G; Lenz-Bauer, C; Aguzzi, A (2008). Canine MDCK cell lines are refractory to infection with human and mouse prions. Vaccine, 26(21):2601-2614.

[img]
Preview
Accepted Version
PDF
3MB

Abstract

Influenza vaccine production in embryonated eggs is associated with many disadvantages, and production in cell culture systems is a viable alternative. Madin Darby canine kidney (MDCK) cells are permissive for a variety of orthomyxoviruses and have proven particularly suitable for vaccine mass production. However, mammalian cells harboring the Prnp gene can theoretically acquire prion infections. Here, we have attempted to infect MDCK cells and substrains thereof with prions. We found that MDCK cells did not produce any protease-resistant PrP(Sc) upon exposure to brain homogenates derived from humans suffering from Creutzfeldt-Jakob disease (CJD) or from mice infected with Rocky Mountain Laboratory (RML) scrapie prions. Further, transmission of MDCK lysates to N2aPK1 cells did not induce formation of PrP(Sc) in the latter. PrP(C) biogenesis and processing in MDCK cells were similar to those of prion-sensitive N2aPK1 cells. However, steady-state levels of PrP(C) were very low, and PrP(C) did not partition with detergent-resistant membranes upon density gradient analysis. These factors may account for their resistance to infection. Alternatively, prion resistance may be related to the specific sequence of canine Prnp, as suggested by the lack of documented prion diseases in dogs.

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Neuropathology
DDC:570 Life sciences; biology
610 Medicine & health
Language:English
Date:2008
Deposited On:31 Oct 2008 08:12
Last Modified:23 Nov 2012 12:22
Publisher:Elsevier
ISSN:0264-410X
Publisher DOI:doi:10.1016/j.vaccine.2008.03.035
PubMed ID:18423803
Citations:Google Scholar™
Scopus®. Citation Count: 24

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page